缺氧对大鼠6种药物转运体基因表达影响的差异性研究
Difference in Effects of Hypoxia on Gene Expressions of Six Drug Transporters in Rats
查看参考文献27篇
|
文摘
|
目的初步探讨缺氧时Pept1、Oatp1b1、Oat1、Oct1、Mdr1和Mrp2 6种药物转运体基因表达的变化。方法Wistar大鼠随机分为正常对照组、缺氧24h和72h组,缺氧组置于模拟海拔5000m(压力:397.5mmHg,氧分压:42mmHg)的低压氧舱中。提取各组大鼠小肠、肝脏、肾脏组织中的总RNA,以Real-time PCR方法检测6种药物转运体基因表达量。结果与正常对照组相比,缺氧组中6种药物转运体基因表达大多数升高,但随着时间的延长,不同组织中的不同转运体出现不一样的变化趋势。结论高原缺氧会影响药物转运体mRNA的表达水平,这可为高原药物转运体及药代动力学研究提供一定的理论依据。 |
|
其他语种文摘
|
Objective To study the gene expressions of six drug transporters-Pept1,Oatp1b1,Oat1, Oct1,Mdr1and Mrp2in rats after acute hypoxia at high altitude.Methods Wistar rats were randomly divided into normal control group,hypoxia 24hgroup and hypoxia 72hgroup.The experimental groups (hypoxia 24hand 72hgroups)were fed in a hypobaric chamber simulated to an altitude of 5000 m (pressure:397.5mmHg,the oxygen partial pressure:42mmHg).Total RNA was extracted from the small intestine,liver and kidney of rats in each group.Real-time PCR was used to detect the expression levels of six transporter genes.Results Compared with control group,the expressions of most of the drug transporters Pept1,Oatp1b1,Oat1,Oct1,Mdr1and Mrp2in hypoxia groups were increased,but different transporters in different tissues developed diverse trends with the extension of hypoxia time.Conclusion Hypoxia at high altitude can affect the mRNA expression levels of drug transporters,which may provide some reference for the study of drug transporters and pharmacokinetics at high altitude. |
|
来源
|
解放军药学学报
,2017,33(4):297-301 【扩展库】
|
|
DOI
|
10.3969/j.issn.1008-9926.2017.04.001
|
|
关键词
|
缺氧
;
药物转运体
;
PCR
;
基因表达
;
大鼠
|
|
地址
|
1.
兰州大学药学院, 全军高原损伤防治重点实验室, 甘肃, 兰州, 730000
2.
兰州大学药学院, 甘肃, 兰州, 730000
3.
兰州军区兰州总医院, 全军高原损伤防治重点实验室, 甘肃, 兰州, 730050
|
|
语种
|
中文 |
|
文献类型
|
研究性论文 |
|
ISSN
|
1008-9926 |
|
学科
|
药学 |
|
基金
|
国家重大科技专项
;
国家自然科学基金
;
全军后勤科研“十二五”重大项目
;
全军医学科研" 十二五" 重点项目
;
甘肃省自然科学基金
|
|
文献收藏号
|
CSCD:6166816
|
参考文献 共
27
共2页
|
|
1.
Arancibia A. Pharmacokinetics of prednisolone in man during acute and chronic exposure to high altitude.
Int J Clin Pharmacol Ther,2005,43(2):85-91
|
CSCD被引
9
次
|
|
|
|
|
2.
Li X Y. Comparison of the pharmacokinetics of sulfamethoxazole in native Han and Tibetan male Chinese volunteers living at high altitude.
Eur J Drug Metab Pharmacokinet,2012,37(4):263-269
|
CSCD被引
1
次
|
|
|
|
|
3.
Rodway G W. High-altitude-related disorders-part I:pathophysiology,differential diagnosis, and treatment.
Heart Lung,2003,32(6):353-359
|
CSCD被引
6
次
|
|
|
|
|
4.
张娟红. 高原环境对醋甲唑胺在大鼠体内药代动力学的影响.
解放军药学学报,2013,29(4):318-320
|
CSCD被引
3
次
|
|
|
|
|
5.
Li W. MDR1will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks.
Drug Metab Rev,2015,47(2):191-198
|
CSCD被引
6
次
|
|
|
|
|
6.
Ribeiro A L. Drug metabolism and transport under hypoxia.
Curr Drug Metab,2013,14(9):969-975
|
CSCD被引
7
次
|
|
|
|
|
7.
张健. 药物转运体介导的小肠吸收、肾脏排泄与药物相互作用的关系.
药学学报,2010,45(9):1089-1094
|
CSCD被引
4
次
|
|
|
|
|
8.
Nigam S K. What do drug transporters really do.
Nat Rev Drug Discov,2015,14(1):29-44
|
CSCD被引
13
次
|
|
|
|
|
9.
Arancibia A. Effects of high altitude exposure on the pharmacokinetics of furosemide in healthy volunteers.
Int J Clin Pharmacol Ther,2004,42(6):314-320
|
CSCD被引
8
次
|
|
|
|
|
10.
Wenbin L. Effects on pharmacokinetics of propranolol and other factors in rats after acute exposure to high altitude at 4,010m.
Cell Biochem Biophys,2015,72(1):27-36
|
CSCD被引
5
次
|
|
|
|
|
11.
张娟玲. 高原低氧影响药物代谢的研究进展.
药学学报,2015,50(9):1073-1079
|
CSCD被引
4
次
|
|
|
|
|
12.
Brandsch M. Pharmaceutical and pharmacological importance of peptide transporters.
J Pharm Pharmacol,2008,60(5):543-585
|
CSCD被引
9
次
|
|
|
|
|
13.
Brandsch M. Drug transport via the intestinal peptide transporter PepT1.
Curr Opin Pharmacol,2013,13(6):881-887
|
CSCD被引
8
次
|
|
|
|
|
14.
Warsi J. Downregulation of peptide transporters PEPT1and PEPT2by oxidative stress responsive kinase OSR1.
Kidney Blood Press Res,2014,39(6):591-599
|
CSCD被引
3
次
|
|
|
|
|
15.
Gonzalez D E. An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1and Capan-2.
Cancer Res,1998,58(3):519-525
|
CSCD被引
3
次
|
|
|
|
|
16.
肖熠. 有机阴离子转运多肽介导的药物相互作用研究进展.
药学与临床研究,2014,22(3):257-261
|
CSCD被引
2
次
|
|
|
|
|
17.
Zhang Q. Organic anion transporter OAT1undergoes constitutive and protein kinase C-regulated trafficking through a dynamin-and clathrin-dependent pathway.
J Biol Chem,2008,283(47):32570-32579
|
CSCD被引
4
次
|
|
|
|
|
18.
Yan S. Research progress in the organic cation transporters.
J Cent South Univ,2011,36(10):913-926
|
CSCD被引
1
次
|
|
|
|
|
19.
Le Vee M. Regulation of drug transporter expression by oncostatin M in human hepatocytes.
Biochem Pharmacol,2011,82(3):304-311
|
CSCD被引
3
次
|
|
|
|
|
20.
Le Vee M. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.
Drug Metab Dispos,2009,37(3):685-693
|
CSCD被引
5
次
|
|
|
|
|
了解气象卫星更多信息，请访问